How Does the Quality of Phospholipidosis Data Influence the Predictivity of Structural Alerts?
Explore this paper's citation graph
Summary
Evaluation of the updated SMARTS model showed a strong, positive correlation between predictive performance of the alerts and the quality of the data set used for the assessment, confirming the importance of using high quality data for modeling and evaluation, especially in the case of PLD.
- Type
- article
- Published
- 2014-08-07
- Cited by
- 33
- References
- 53
- OpenAlex
- https://openalex.org/W2091018730
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31785369
Keywords
Phospholipidosis, Computer science, Data mining, Quality (philosophy), Chemistry
References
- Lysosomal metabolism of lipids.
- A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
- Drug-Induced Phospholipidosis: Are There Functional Consequences?
- Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
- Modeling Phospholipidosis Induction: Reliability and Warnings
- Drug-induced phospholipidosis: issues and future directions
- An in Vitro Fluorescence Assay for the Detection of Drug-Induced Cytoplasmic Lamellar Bodies
- Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds.
- Pitfalls in QSAR
- High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
- A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
- pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery.
- Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data
- Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis.
- A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development
- Predicting Phospholipidosis Using Machine Learning
- Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.
- Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1).
- Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures.
- Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds
Cited by
- Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
- FAF-Drugs3: a web server for compound property calculation and chemical library design
- Toward a unifying strategy for the structure-based prediction of toxicological endpoints
- Computer-aided drug design at Boehringer Ingelheim
- In Silico Prediction of Organ Level Toxicity: Linking Chemistry to Adverse Effects
- Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods
- Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen.
- Relationship Between Adverse Outcome Pathways and Chemistry-Based In Silico Models to Predict Toxicity
- FilTer BaSe: A web accessible chemical database for small compound libraries.
- Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
- A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity.
- 5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma
- Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential.
- A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments
- The Application of Negative Design to Design More Desirable Virtual Screening Library.
- Modeling Binary Fingerprint Descriptors With the Superposing Significant Interaction Rules (SSIR) Method
- Scopy: an integrated negative design python library for desirable HTS/VS database design
- A Review of In Silico Tools as Alternatives to Animal Testing: Principles, Resources and Applications
- COSMOS next generation – A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals
- A novel synthetic protocol for the synthesis of pulvinones, and naturally occurring Aspulvinone E, molecules of medicinal interest
Related papers
- In vitro assays and biomarkers for drug-induced phospholipidosis
- High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
- Phospholipidosis effect of drugs by adsorption into lipid monolayers.
- A role for lysosomal phospholipase A2 in drug induced phospholipidosis.
- Inhibition of lysosomal phospholipase A2 predicts drug-induced phospholipidosis
- Alveolar macrophage mediated pulmonary clearance suppressed by drug-induced phospholipidosis.
- Drug‐induced phospholipidosis